or Try an Advanced Search...

    Technical Analysis for TBPH - Theravance Biopharma, Inc.

    Grade Last Price % Change Price Change
    C 9.43 -0.63% -0.06
    TBPH closed down 0.52 percent on Wednesday, May 8, 2024, on 72 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
    Earnings due: May 13
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical TBPH trend table...
    Date Alert Name Type % Chg
    200 DMA Resistance Bearish -0.63%
    NR7 Range Contraction -0.63%
    Fell Below 200 DMA Bearish -1.15%
    Spinning Top Other -1.15%
    Crossed Above 200 DMA Bullish -1.77%
    MACD Bullish Centerline Cross Bullish -1.77%
    MACD Bullish Signal Line Cross Bullish -1.77%
    Pocket Pivot Bullish Swing Setup -1.77%
    Multiple of Ten Bearish Other -1.77%
    Gapped Up Strength -1.77%
    Older End-of-Day Signals for TBPH ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Support 28 minutes ago
    Fell Below Previous Day's Low 35 minutes ago
    Down 1% 35 minutes ago
    Possible NR7 about 20 hours ago
    Possible Inside Day about 20 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    TBPH Chart by TradingView
    Basic chart:

    Profile

    Theravance Biopharma, Inc. operates as a biopharmaceutical company. It provides discovery, development, and commercialization of small molecule medicines primarily for therapeutic areas of respiratory diseases, bacterial infections, and central nervous system (CNS)/pain. The company is based in George Town, Cayman Islands. Theravance Biopharma, Inc. operates as a subsidiary of Theravance Inc.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Pain Medication Respiratory Diseases Bacterial Infections

    Is TBPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 29 Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024
    Apr 15 BTIG Research Predicts Over 118% Rally for These 3 Stocks
    Apr 15 Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?
    Apr 10 Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024
    Apr 3 Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?
    Mar 27 Why Is Theravance Bio (TBPH) Down 9% Since Last Earnings Report?
    Mar 12 Short-Squeeze Showdown: 3 Stocks Ready to Crush the Skeptics
    Feb 28 Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript
    Feb 27 Theravance's (TBPH) Q4 Earnings & Revenues Surpass Estimates
    Feb 27 Theravance Biopharma, Inc. (TBPH) Q4 2023 Earnings Call Transcript
    See more TBPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.71
    52 Week Low 8.21
    Average Volume 417,265
    200-Day Moving Average 9.60
    50-Day Moving Average 9.11
    20-Day Moving Average 9.30
    10-Day Moving Average 9.20
    Average True Range 0.41
    RSI (14) 54.75
    ADX 19.99
    +DI 29.89
    -DI 18.05
    Chandelier Exit (Long, 3 ATRs) 9.20
    Chandelier Exit (Short, 3 ATRs) 9.64
    Upper Bollinger Bands 9.97
    Lower Bollinger Band 8.64
    Percent B (%b) 0.64
    BandWidth 14.25
    MACD Line 0.06
    MACD Signal Line 0.03
    MACD Histogram 0.0335
    Fundamentals Value
    Market Cap 472.58 Million
    Num Shares 49.8 Million
    EPS -1.03
    Price-to-Earnings (P/E) Ratio -9.21
    Price-to-Sales 7.89
    Price-to-Book 1.74
    PEG Ratio -0.05
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.82
    Resistance 3 (R3) 9.83 9.73 9.77
    Resistance 2 (R2) 9.73 9.65 9.73 9.75
    Resistance 1 (R1) 9.61 9.59 9.56 9.60 9.73
    Pivot Point 9.51 9.51 9.49 9.51 9.51
    Support 1 (S1) 9.39 9.43 9.34 9.38 9.25
    Support 2 (S2) 9.29 9.37 9.29 9.23
    Support 3 (S3) 9.17 9.29 9.22
    Support 4 (S4) 9.16